ArticleJournal of thoracic disease2013
Chinese multi-institutional registry (CMIR) for resected non-small cell lung cancer: survival analysis of 5,853 cases.
Article in Journal of thoracic disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- What comes next after establishing evidence for video-assisted thoracic surgery lobectomy in early-stage lung cancer?Journal of thoracic disease · 2026Article
- Efficiency of pulmonary nodule risk scoring systems in Turkish population.Updates in surgery · 2024Article
- The study of plain CT combined with contrast-enhanced CT-based models in predicting malignancy of solitary solid pulmonary nodules.Scientific reports · 2024Article
- Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study.JMIR public health and surveillance · 2023Article
- Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset.Frontiers in oncology · 2023Article
- Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China.Translational lung cancer research · 2022Article
- Lung cancer screening with low-dose computed tomography: National expenditures and cost-effectiveness.Frontiers in public health · 2022Article
- Determining cost-effectiveness of lung cancer screening in urban Chinese populations using a state-transition Markov model.BMJ open · 2021Article
- Should sublobar resection be offered for screening-detected lung nodules?Translational lung cancer research · 2021Review
- Clinical characteristics and work-up of small to intermediate-sized pulmonary nodules in a Chinese dedicated cancer hospital.Cancer biology & medicine · 2020Article
- Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical population.Translational lung cancer research · 2019Article
- Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice.Chinese journal of cancer · 2017Article
- Design and implementation of a mobile system for lung cancer patient follow-up in China and initial report of the ongoing patient registry.Oncotarget · 2017Article
- OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling.American journal of cancer research · 2015Article
- Safety and feasibility of video-assisted thoracoscopic surgery for stage IIIA lung cancer.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConcerns on surgical treatment of non-small cell lung cancer (NSCLC) have been increasing recent years. However, the significance of previous studies based on single center or regional experience in China was impaired by small sample size. Here we described a Chinese Multi-institutional Registry (CMIR) to address this disadvantage and proposed a further collaboration project.
methodsInformation of patients diagnosed with stage I to III NSCLC who underwent radical resection between 2001 and 2008 in seven institutions from the People's Republic of China was collected using a blinded standardized data form. Survival outcomes were calculated by Kaplan-Meier curves and Life-table method.
resultsA total of 5,853 patients who met the inclusion criteria were entered into the database. The average age was 58.9±10.7 years. Males (59.5%) and adenmocarcinoma (53.0%) represented the majority of all cases. Lobectomy (87.9%) was the major operation type in practice. The 5-year overall survival rates were 81.9% for stage IA, 71.6% for IB, 55.0% for IIA, 45.2% for IIB, 34.9% for IIIA and 23.3% for IIIB (P<0.001).
conclusionsThis is the first and the largest clinical database for resected NSCLC in China with optimal data quality. Future collaboration to expand and share this database nationwide is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.